Table 2.
Overall Perform ance, %* |
Performance, %* | Performance, %* | Performance, %* | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Quality Indicator |
No Compensat ion for quality |
Compens ation for quality |
Adjus ted† analys is p- value |
No Compensa tion for satisfactio n |
Compensa tion for satisfactio n |
Adjusted † analysis p-value |
No Public reporti ng |
Public reporti ng |
Adjus ted† analys is p- value |
|
Preventative Care Measures Group | ||||||||||
Advising smokers and tobacco users to quit | 25.0 | 21.8 | 36.7 | 0.73 | 21.3 | 42.8 | 0.02 | 24.1 | 30.5 | 0.64 |
BMI screening | 49.5 | 49.7 | 48.9 | 0.02 | 47.8 | 56.2 | 0.004 | 49.5 | 49.6 | 0.85 |
Weight reduction counseling for overweight patients | 12.0 | 10.0 | 17.8 | 0.36 | 10.5 | 16.8 | 0.90 | 10.0 | 25.5 | 0.01 |
Urinalysis not performed at visit | 93.0 | 93.3 | 92.2 | 0.17 | 92.9 | 93.2 | 0.36 | 93.1 | 92.3 | 0.84 |
Diabetes Mellitus Measures Group | ||||||||||
Blood Pressure Management | 45.4 | 44.7 | 48.0 | 0.30 | 45.3 | 46.0 | 0.34 | 45.7 | 42.7 | 0.98 |
Heart Failure Measures Group | ||||||||||
ACE-inhibitor or ARB therapy | 43.5 | 45.1 | 38.6 | 0.09 | 42.9 | 46.2 | 0.08 | 45.4 | 31.9 | 0.24 |
Beta blocker therapy | 57.1 | 58.7 | 55.4 | 0.88 | 57.6 | 55.4 | 0.92 | 55.3 | 71.4 | 0.03 |
Coronary Artery Disease Measures Group | ||||||||||
Oral Antiplatelet therapy | 48.9 | 50.0 | 44.5 | 0.29 | 50.6 | 40.0 | 0.18 | 49.1 | 47.8 | 0.89 |
Beta blocker therapy | 48.8 | 50.1 | 43.4 | 0.33 | 49.6 | 44.1 | 0.78 | 48.1 | 53.4 | 0.48 |
Miscellaneous | ||||||||||
No antibiotics for upper respiratory infection | 45.5 | 49.3 | 67.1 | 0.08 | 51.3 | 63.8 | 0.52 | 46.0 | 39.1 | 0.80 |
Anticoagulation therapy in patients with Atrial Fibrillation | 64.9 | 63.7 | 69.5 | 0.62 | 64.6 | 66.5 | 0.73 | 46.0 | 39.1 | 0.30 |
Bronchodilator therapy in patients with COPD | 59.4 | 50.3 | 49.8 | 0.93 | 49.8 | 52.4 | 0.33 | 49.7 | 55.6 | 0.23 |
Abbreviations: CHC – community health center; HMO – health maintenance organization.
Survey weighted percentages based on the population that was sampled.
Adjusted for patient age, gender, race/ethnicity, primary source of payment, and number of comorbid condition, practice size, practice type, physician employment status, physician specialty category, region, urban location, and presence of other incentives for quality.